Jan Godzinski
Overview
Explore the profile of Jan Godzinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
788
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Virgone C, Roganovic J, Vorwerk P, Redlich A, Schneider D, Janic D, et al.
Pediatr Blood Cancer
. 2021 Jun;
68 Suppl 4:e29025.
PMID: 34174161
Adrenocortical tumours (ACTs) are rare during childhood. A complete surgical resection provides the best chance of cure, but the role and efficacy of the adjuvant therapy are still controversial. Various...
12.
Ferrari A, Almaraz R, Reguerre Y, Cesen M, Bergamaschi L, Indini A, et al.
Pediatr Blood Cancer
. 2021 Jun;
68 Suppl 4:e28992.
PMID: 34174159
Cutaneous melanoma is rare in children and, like other very rare pediatric tumors, it suffers from a shortage of knowledge and clinical expertise. The clinical management of pediatric melanoma is...
13.
Ferrari A, Schneider D, Bisogno G, Reguerre Y, Godzinski J, Bien E, et al.
Pediatr Blood Cancer
. 2021 Jun;
68 Suppl 4:e28993.
PMID: 34174158
It has become increasingly clear in recent years that we need to develop ad hoc strategies to combat very rare tumors (VRT) of pediatric age. In 2008, several schemes being...
14.
Bien E, Roganovic J, Krawczyk M, Godzinski J, Orbach D, Cecchetto G, et al.
Pediatr Blood Cancer
. 2021 Jun;
68 Suppl 4:e29112.
PMID: 34174157
Pancreatoblastoma (PBL) is a rare malignant epithelial neoplasm that affects typically young children. Signs related to advanced upper-abdominal tumor accompanied by elevated serum α-fetoprotein levels in a young child suggest...
15.
Styczewska M, Patel A, Jaskulowska J, Godzinski J, Swieton D, Wasag B, et al.
Anticancer Drugs
. 2021 Jun;
32(10):1111-1115.
PMID: 34145176
Inflammatory myofibroblastic tumor (IMT) is a rare borderline malignancy, usually treated with surgery only. Exceedingly rare cases of inoperable, recurrent, or metastatic IMTs pose a therapeutic challenge. We report successful...
16.
Jeremiasse B, van der Steeg A, Fiocco M, Hobbelink M, Merks J, Godzinski J, et al.
Ann Surg Oncol
. 2021 May;
28(13):9048-9059.
PMID: 34057567
Background: Our aim is to show whether the sentinel node procedure (SNP) is recommendable for pediatric patients with extremity rhabdomyosarcoma (RMS). Lymph node metastases are an important prognostic factor in...
17.
Orbach D, Ferrari A, Schneider D, Reguerre Y, Godzinski J, Bien E, et al.
Pediatr Blood Cancer
. 2021 Apr;
68 Suppl 4:e29072.
PMID: 33913610
The PARTNER project (Paediatric Rare Tumours Network - European Registry) was launched in 2016. PARTNER aims to create a European Registry dedicated to children and adolescents with very rare tumors...
18.
Stachowicz-Stencel T, Synakiewicz A, Cornet M, Ferrari A, Garassino M, Remon Masip J, et al.
Pediatr Blood Cancer
. 2021 Apr;
68 Suppl 4:e29042.
PMID: 33881200
Thymic tumors are epithelial tumors arising from the anterior mediastinum and constitute 0.2-1.5% of all adult malignancies but are exceptional in pediatric population. Thymic epithelial tumors (TETs) encompass a variety...
19.
Bisogno G, Sarnacki S, Stachowicz-Stencel T, Minard Colin V, Ferrari A, Godzinski J, et al.
Pediatr Blood Cancer
. 2021 Apr;
68 Suppl 4:e29045.
PMID: 33826235
Pleuropulmonary blastoma (PPB) is a rare cancer occurring mainly during early childhood and often associated with germline DICER1 mutations. It is classified by the macroscopic appearance into three interrelated clinico-pathologic...
20.
Schneider D, Orbach D, Ben-Ami T, Bien E, Bisogno G, Brecht I, et al.
Pediatr Blood Cancer
. 2021 Mar;
68 Suppl 4:e29017.
PMID: 33760357
As part of the European Union-funded project designated Paediatric Rare Tumours Network - European Registry (PARTNER), the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) is continuously developing consensus...